Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
about
Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA.Clinical significance of LMO1 in gastric cancer tissue and its association with apoptosis of cancer cells.Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance.
P2860
Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Simultaneous delivery of Pacli ...... rgistic treatment of melanoma.
@en
type
label
Simultaneous delivery of Pacli ...... rgistic treatment of melanoma.
@en
prefLabel
Simultaneous delivery of Pacli ...... rgistic treatment of melanoma.
@en
P2093
P2860
P356
P1433
P1476
Simultaneous delivery of Pacli ...... rgistic treatment of melanoma.
@en
P2093
B V Subba Reddy
Koteswara Rao Garikapati
Manika Pal Bhadra
S Gopal Reddy
Teegala Lakshminarayan Reddy
Utpal Bhadra
P2860
P2888
P356
10.1038/SREP35223
P407
P577
2016-10-27T00:00:00Z
P6179
1001507812